Answers are grounded in this paper and cite their sources.
Diagnosis of glycogen storage disease type I is delayed in Brazil. Most patients undergo liver biopsy for diagnostic confirmation, even though the combination of a characteristic clinical presentation and molecular methods can provide a definitive diagnosis in a less invasive manner. Obesity is a side effect of cornstarch therapy, and appears to be associated with growth in these patients.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: